Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
7 studies found for:    "NJMS" OR "New Jersey Medical School" | Open Studies | "Liver Diseases"
Show Display Options
Rank Status Study
1 Recruiting Novel Gallium Imaging in Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Intervention: Drug: 68Gallium Citrate
2 Recruiting Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment
Condition: Non Alcoholic Steatohepatitis (NASH)
Interventions: Drug: Obeticholic Acid;   Drug: Placebo
3 Recruiting Remote Ischemic Conditioning (RIC) in Recipients of Brain Death Donor Livers - A Feasibility and Safety Study
Conditions: Liver Failure;   Carcinoma, Hepatocellular
Interventions: Procedure: Remote Ischemic Conditioning (RIC);   Device: Pneumatic tourniquet
4 Recruiting Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Condition: Nonalcoholic Steatohepatitis (NASH) With Fibrosis
Interventions: Drug: Elafibranor;   Drug: Placebo
5 Recruiting Mobilization of Mesenchymal Stem Cells During Liver Transplantation
Conditions: Liver Failure;   Liver Neoplasm
Intervention: Procedure: blood samples
6 Recruiting HepaSphere/Quadrasphere Microspheres for Delivery of Doxorubicin for the Treatment of Hepatocellular Cancer
Condition: Hepatocellular Carcinoma
Interventions: Device: HepaSphere/QuadraSphere Microspheres;   Procedure: PVA, lipiodol, doxorubicin
7 Recruiting Evaluating the Safety and Effectiveness of Interferon-Free Treatment of Hepatitis C Virus Infection in HIV-Coinfected Adults on Antiretroviral Therapy
Condition: HIV Infections
Interventions: Drug: Paritaprevir/ritonavir/ombitasvir (PTV/r/OBT);   Drug: Dasabuvir (DSV);   Drug: Ribavirin (RBV)

Study has passed its completion date and status has not been verified in more than two years.